Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214501-25-000004
Filing Date
2025-10-28
Accepted
2025-10-28 18:30:09
Documents
1
Period of Report
2025-10-28

Document Format Files

Seq Description Document Type Size
1 form4-10282025_061005.html 4  
1 form4-10282025_061005.xml 4 13325
  Complete submission text file 0001214501-25-000004.txt   14889
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address
MIDDLEKAUFF W BRADFORD (Reporting) CIK: 0001214501 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 251426186

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)